- Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes
-
Vrba L, Futscher B
- KMID: 2389758
- J Breast Cancer.
- 2017 Jun;20(2):198-202.
- doi: 10.4048/jbc.2017.20.2.198
Immortality is an essential characteristic of cancer cells; a recent transcriptomic study of epithelial cell immortalization has linked epigenetic silencing of the long noncoding RNA Mortal Obligate RNA Transcript (MORT;... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Breast Cancer Brain Metastasis with a 16-Year Time Interval without Evidence of Cancer Recurrence
-
Yamada SM, Tomita Y, Shibui S, Kurokawa T, Baba Y
- KMID: 2389761
- J Breast Cancer.
- 2017 Jun;20(2):212-216.
- doi: 10.4048/jbc.2017.20.2.212
The median time of brain metastasis from the diagnosis of breast cancer is approximately 3 years. In this case report, a 69-year-old woman demonstrated cerebellar ataxia. Brain magnetic resonance imaging... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic Myeloid Leukemia with a Complex Variant ‘Ph’ Translocation That Develops in Breast Carcinoma, Postchemotherapy: A Rare but Treatable Entity
-
Tikku G, Jain M, Shukla P
- KMID: 2389760
- J Breast Cancer.
- 2017 Jun;20(2):208-211.
- doi: 10.4048/jbc.2017.20.2.208
We report a case of chronic myeloid leukemia (CML) that developed after postoperative chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) for breast cancer. A 55-year-old woman was diagnosed with invasive... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging Surveillance for Survivors of Breast Cancer: Correlation between Cancer Characteristics and Method of Detection
-
Chu AJ, Chang JM, Cho N, Moon WK
- KMID: 2389757
- J Breast Cancer.
- 2017 Jun;20(2):192-197.
- doi: 10.4048/jbc.2017.20.2.192
PURPOSE: The aim of our study was to investigate the characteristics of primary and recurrent breast cancers and the correlation between cancer subtypes and detection modes. METHODS: Between 2003 and 2013,... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in the Neoadjuvant Treatment of Breast Cancer
-
Rubovszky , Horváth Z
- KMID: 2389749
- J Breast Cancer.
- 2017 Jun;20(2):119-131.
- doi: 10.4048/jbc.2017.20.2.119
In the last few decades, neoadjuvant therapy for breast cancer has gained considerable therapeutic importance. Despite extensive clinical investigations, it has not yet been clarified whether neoadjuvant therapy would result... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of the Angelina Jolie Announcement and Insurance Reimbursement on Practice Patterns for Hereditary Breast Cancer
-
Lee J, Kim S, Kang E, Park S, Kim Z, Lee MH, The Korean Breast Cancer Society
- KMID: 2389759
- J Breast Cancer.
- 2017 Jun;20(2):203-207.
- doi: 10.4048/jbc.2017.20.2.203
Lack of awareness, the stigma of carrying a genetic mutation, and economic factors are barriers to acceptance of BRCA genetic testing or appropriate risk management. We aimed to investigate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Impact of Progesterone Receptor Status in Chinese Estrogen Receptor Positive Invasive Breast Cancer Patients
-
Yao N, Song Z, Wang X, Yang S, Song H
- KMID: 2389753
- J Breast Cancer.
- 2017 Jun;20(2):160-169.
- doi: 10.4048/jbc.2017.20.2.160
PURPOSE: Estrogen receptor (ER) and progesterone receptor (PR) have been used as indicators of endocrine system status since the mid-1970s in the clinical management of breast cancer. The predictive role... -
- CITED
-
- Close
- SHARE
-
- Close
- Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis
-
Shen G, He P, Mao Y, Li P, Luh F, Ding G, Liu X, Yen Y
- KMID: 2389750
- J Breast Cancer.
- 2017 Jun;20(2):132-141.
- doi: 10.4048/jbc.2017.20.2.132
PURPOSE: Uridine-cytidine kinase (UCK) 2 is a rate-limiting enzyme involved in the salvage pathway of pyrimidine-nucleotide biosynthesis. Recent studies have shown that UCK2 is overexpressed in many types of cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening Uptake Differences Are Not Implicated in Poorer Breast Cancer Outcomes among Singaporean Malay Women
-
Xin WR, Kwok LL, Yong WF
- KMID: 2389756
- J Breast Cancer.
- 2017 Jun;20(2):183-191.
- doi: 10.4048/jbc.2017.20.2.183
PURPOSE: This study was undertaken to examine the impact of screening and race on breast cancer outcomes in Singapore. METHODS: An institutional database was reviewed, and invasive ductal carcinoma (IDC) and... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
-
Kim A, Jang MH, Lee SJ, Bae YK
- KMID: 2389752
- J Breast Cancer.
- 2017 Jun;20(2):150-159.
- doi: 10.4048/jbc.2017.20.2.150
PURPOSE: Epidermal growth factor receptor (EGFR) is considered a potential therapeutic target for anti-EGFR therapy in triple-negative breast cancer (TNBC). However, the frequency of EGFR gene mutation in TNBC is... -
- CITED
-
- Close
- SHARE
-
- Close
- CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer
-
Ye F, Zhong X, Qiu Y, Yang L, Wei B, Zhang Z, Bu H
- KMID: 2389751
- J Breast Cancer.
- 2017 Jun;20(2):142-149.
- doi: 10.4048/jbc.2017.20.2.142
PURPOSE: Metastasis and local recurrence are the primary causes of treatment failure and patient death in breast cancer. The aim of this study was to validate a metastasis- and local... -
- CITED
-
- Close
- SHARE
-
- Close
- The Usefulness of Intraoperative Circumferential Frozen-Section Analysis of Lumpectomy Margins in Breast-Conserving Surgery
-
Ko S, Chun YK, Kang SS, Hur MH
- KMID: 2389755
- J Breast Cancer.
- 2017 Jun;20(2):176-182.
- doi: 10.4048/jbc.2017.20.2.176
PURPOSE: Intraoperative frozen-section analysis of the lumpect-omy margin during breast-conserving surgery (BCS) is an excellent method in obtaining a clear resection margin. This study aimed to investigate the usefulness of... -
- CITED
-
- Close
- SHARE
-
- Close
- High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers
-
Mandó P, Rizzo M, de la Puente CP, Maino M, Ponce C, Pombo MT, Amat M, Costanzo M, Nervo A, Nadal J, Fabiano V, Loza J, Loza CM, Colo F, Reinaldo C
- KMID: 2389754
- J Breast Cancer.
- 2017 Jun;20(2):170-175.
- doi: 10.4048/jbc.2017.20.2.170
PURPOSE: Several studies have shown that estrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) expression may vary during tumoral progression. We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
